OmsætningOverskudP/EKUVEBITUdbytteAktierMarkedsværdiGældForpligtelserEgenkapitalAAQSMedarbejdereROEROAROCE

Lifco AB (publ) AAQS 2024

Lifco AB (publ) AAQS

9

Lifco AB (publ) Udbytterendite

0,65 %

Ticker

LIFCO B.ST

ISIN

SE0006370730

Lifco AB (publ) har en aktuel AAQS på 9. En høj AAQS kan betragtes som et positivt tegn på, at virksomheden udvikler sig succesfuldt. Investorerne kan forvente, at virksomheden er på rette spor mod at skabe overskud. På den anden side er det vigtigt at betragte AAQS for aktien Lifco AB (publ) i forhold til de opnåede overskud og sammenligne med andre virksomheder i samme branche. En høj AAQS er ikke en absolut garanti for en positiv fremtid. Det er kun på den måde, man kan få et komplet billede af virksomhedens præstationer. For bedre at kunne vurdere virksomhedens udvikling er det vigtigt at betragte AAQS i sammenligning med andre virksomheder i samme branche. Generelt bør investorer altid betragte en virksomheds AAQS i sammenhæng med andre nøgletal som overskud, EBIT, cash flow og andre for at træffe en velbaseret investeringsbeslutning.

Lifco AB (publ) Aktienanalyse

Hvad gør Lifco AB (publ)?

Lifco AB (publ) is a Swedish company that operates in the distribution industry and specializes in acquiring and developing small and medium-sized enterprises. The company was founded in 1990 by Carl Bennet and is headquartered in Stockholm. Since its founding, Lifco AB has experienced impressive growth and has established various divisions within the company, including dental, laboratory, medical, pharmaceutical, electronics, and security. The company's goal is to offer its customers a wide range of high-quality products through the acquisition of companies and equity investments. Lifco AB is dedicated to providing its customers with products and solutions that bring value to their businesses. The company invests in research and development to improve products and promote innovation, enabling its customers to work more efficiently and profitably. One of Lifco AB's divisions, for example, is the dental sector. The company offers its customers various products and solutions in the field of dentistry, ranging from treatment units to instruments and devices, all of which are of the highest quality. Through acquisitions, the company has continuously expanded its range of products, thereby offering customers a broader selection. The company also offers innovative products in the field of laboratory work. The product range includes solutions for in-vitro fertilization (IVF) and the use of polymerase chain reaction (PCR), leveraging Lifco AB's expertise in the technology and medical sectors. Other divisions of Lifco AB include the medical sector, where the company offers products and solutions in areas such as surgery, decontamination, and dialysis, as well as the pharmaceutical sector, which includes products in the areas of veterinary medicine, human health, and dermatology. Another business area of Lifco AB is electronics, where the company offers products in the areas of security, audio, and communication technology. Lifco AB's expertise in the electronics industry plays a crucial role in this division. In the security sector, the company offers products such as surveillance cameras, alarm systems, and access control systems. The audio division includes products such as speakers, microphones, and amplifiers, while the communication division offers products such as telephones and video conferencing systems. In summary, Lifco AB is an internationally operating company that has built a wide range of products and solutions through the acquisition of small and medium-sized enterprises. The company strives to promote innovation and quality in all its business areas in order to provide its customers with real value. Lifco AB consistently strengthens its position in the market and expands its customer base. Lifco AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Ofte stillede spørgsmål om Lifco AB (publ) aktien

Aktiespareplaner tilbyder en attraktiv mulighed for investorer at opbygge formue på lang sigt. En af de største fordele er den såkaldte cost-average-effekt: Ved regelmæssigt at investere et fast beløb i aktier eller aktiefonde, køber man automatisk flere andele, når priserne er lave, og færre, når de er høje. Dette kan føre til en mere fordelagtig gennemsnitspris per andel over tid. Desuden giver aktiespareplaner også småinvestorer adgang til dyre aktier, da de kan deltage med små beløb. Den regelmæssige investering fremmer også en disciplineret investeringsstrategi og hjælper med at undgå følelsesladede beslutninger, som impulsiv køb eller salg. Derudover drager investorer fordel af den potentielle værdistigning af aktierne samt af udbytteudlodninger, der kan geninvesteres, hvilket forstærker renters rente effekten og dermed væksten af det investerede kapital.

Andere Kennzahlen von Lifco AB (publ)

Vores aktieanalyse af Lifco AB (publ) Omsætning-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Lifco AB (publ) Omsætning. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: